SP
Synact Pharma / Sedermera Stock: price and insider trades · Sweden
Synact Pharma / Sedermera: what insiders have been doing
We have very little insider data for Synact Pharma / Sedermera so far: the most recent filing dates from 4 May 2018. With so few records, no pattern can be drawn yet. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
· cache
Last declaration on 4 May 2018
Declarations1 total
- 30,302 shares@ SEK 9.90100.0% of flowFI:csv-2d22f12db5805d6d3fa7
1 of 1 declaration
About Synact Pharma / Sedermera
Synact Pharma is a biopharmaceutical company focused on developing treatments for inflammatory and autoimmune diseases. Sedermera is an investment advisory firm that supports companies in the healthcare sector.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations